HYPD Hyperion DeFi, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Hyperion DeFi (HYPD) Stock: Buy, Sell, or Hold?

$2.72
+0.01 (+0.37%) ▲
5d: +6.25% 30d: -11.97% 90d: +0.0%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (91%)
Quality Score
56/100
Position
SLIGHTLY LOW
30-Day Fair Range
$2.71 – $3.43
Position: SLIGHTLY LOW
Forward P/E & Valuation
1.1x CHEAP
vs 4.7x historical avg
Wall Street Target
$9.83
+261.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.36 / $3.34
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: HYPD trading at deep discount. Market pricing in -38.0% annual earnings decline, creating value opportunity for patient investors.

Get Alerted When HYPD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$1.28
Based on -30.7% avg growth
INTRINSIC VALUE TODAY
$0.79
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: HYPD is currently trading at $2.72, which is considered slightly low relative to its 30-day fair value range of $2.71 to $3.43. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.1) compared to its historical average (4.7). Remarkably, the market is currently pricing in an annual earnings decline of 38.0% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, HYPD is in a uptrend. Immediate support is located at $2.36, while resistance sits at $3.34.

Market Sentiment: HYPD scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.82 (+261.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $2.71 - $3.43
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 90.5%

Trading Range & Key Levels

30-Day Trading Range $2.71 - $3.43
Current vs Trading Range SLIGHTLY LOW
Support Level $2.36
Resistance Level $3.34
Current Trend Uptrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (74/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 261.2% below Wall St target ($9.82)
  • BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up

Fundamental Context

Forward P/E (Next Year Est.) 1.12
Wall Street Target $9.83 (+261.2%)
Revenue Growth (YoY) 1559.5%
Profit Margin 474.9%
Valuation Discount vs History -38.0% cheaper
PE vs Historical 1.1 vs 4.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -38.0% (market-implied from PE analysis)
1-Year Target $2.45 (-10%)
2-Year Target $2.20 (-19%)
3-Year Target $1.98 (-27%)
3-Yr Target (if PE normalizes) (PE: 1→5) $8.29 (+205%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -65.4%) $35.04 (+1188%)
Base: (SPY PE: 1.1, Growth: -65.4%) $1.98 (-27%)
Bear: (PE: 1.0, Growth: -65.4%) $1.69 (-38%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.1 to 4.7
Stabilization Target: $11.37 (+318.2%)
PE Expansion Potential: +318.2%
Share HYPD Analysis

Share this live HYPD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (HYPD)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish trader on StockTwits expresses optimism about $HYPD's potential for significant price growth following recent pullbacks.
Key Retail Themes: positive sentiment towards $HYPD's potential price growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:26 PM ET
Data refreshes hourly during market hours. Next update: 8:26 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for HYPD.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
REGN
Regeneron Pharmaceutical…
BUY
28 analysts
$978 32 SELL
PRAX
Praxis Precision Medicin…
STRONG BUY
21 analysts
$650 32 SELL
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
22 analysts
$296 24 SELL
DYN
Dyne Therapeutics Inc
STRONG BUY
17 analysts
$34 49 HOLD
ACAD
ACADIA Pharmaceuticals I…
STRONG BUY
20 analysts
$31 48 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive HYPD Research Pages
HYPD Technical Chart HYPD Price Prediction HYPD Intrinsic Value DCF HYPD Earnings Date HYPD Investment Advisor HYPD Fair Price Analyzer HYPD Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals